RxDoctor Payments Data

Erik Suarez, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Houston, TXNPI 1356589675

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (52.3%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Paragonix Technologies, Inc. at 28.5% of the total. Reporting peaked in 2019 at $18,377 and has fallen 94.3% since, to $1,056 in 2025.

$42,082in general payments, 2019–2025

Across 110 payments — averaging $382.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Paragonix Technologies, Inc.$12K
  • Medtronic$8K
  • Abiomed$8K
  • Abbott$6K
  • Livanova USA, Inc.$4K
  • Transmedics, Inc.$2K
  • plus $2K from 10 others
$55,472in research payments, 2019–2025

Across 45 payments — averaging $1232.72 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$30K
  • Abbott$19K
  • Transmedics, Inc.$6K

What the payments were for

  • Consulting fees$22,00052%
  • Speaking & faculty fees$7,47018%
  • Travel & lodging$5,52613%
  • Food & beverage$7,08617%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$42,082 in reported general payments places this provider in the 85th percentile of 424 thoracic surgery (cardiothoracic vascular surgery) providers in Texas.

See all thoracic surgery (cardiothoracic vascular surgery) providers in Texas

Medicare billing

Part B allowed, 2024
$94,158
Medicare patients
40
Services billed
75

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other thoracic surgery (cardiothoracic vascular surgery) in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →